foxo4-dri peptide senolytic human trial The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4-DRI 10mg vial - Description
Pay in 4 interest-free payments of $5.66 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 13 - Nov 18




:max_bytes(150000):strip_icc()/VWH-GettyImages-1469751146-5eff6dd0b38449ff9dca9313c7c393d5.jpg)



















